BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11140243)

  • 1. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
    Abraham KA; Little MA; Dorman AM; Walshe JJ
    Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
    Myers JN; Shabshab SF; Burton NA; Nathan SD
    J Heart Lung Transplant; 1999 Oct; 18(10):1024-6. PubMed ID: 10561115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue treatment for cyclosporine-associated hemolytic-uremic syndrome with intravenous immunoglobulin.
    Wen YK; Chen ML
    Clin Nephrol; 2006 Jul; 66(1):58-62. PubMed ID: 16878437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of renal transplant recipients from cyclosporin (neoral) to tacrolimus (prograf) for haemolytic uraemic syndrome.
    Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
    Transpl Int; 1998; 11 Suppl 1():S98-9. PubMed ID: 9664954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
    Gray JM; Ameduri RK
    Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
    Lapointe M; Baillie GM; Bhaskar SS; Richardson MS; Self SE; Baliga PK; Rajagopalan PR
    Clin Transplant; 1999 Dec; 13(6):526-30. PubMed ID: 10617244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B; Abraham G; Srinivas CN; Bhaskar S
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
    Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
    Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 15. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
    Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
    Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
    Grupp C; Schmidt F; Braun F; Lorf T; Ringe B; Müller GA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1629-31. PubMed ID: 9681701
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible hemolytic uremic syndrome in three cats after renal transplantation and cyclosporine therapy.
    Aronson LR; Gregory C
    Vet Surg; 1999; 28(3):135-40. PubMed ID: 10338157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
    Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
    Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.